Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2007 / Cilt: 33 - Sayı: 3

Comparasion of transurethral resection (TURP) and transurethral plasmavapourasation (TUVAP) of prostate in benign prostatic hypertrophy patients by using plasmakinetic tissue treatment systems

Benin prostat hiperplazili hastalarda plasmakinetik doku tedavi sistemi kullanılarak yapılan transüretral rezeksiyon (TURP) ve transüretral plazmavaporizasyon (TUVAP) sonuçlarının karşılaştırılması

Pages
308–316
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that, plasmakinetic tissue treatment system, with TURP and TUVAP procedures, is an effective option in the treatment of BPH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Recently, transurethral plasma vaporization (TUVAP) of BPH by using bipolar plasmakinetic technology has taken its role as a minimal invasive treatment option.
📊
Key Findings & Data:Materials and Methods: 76 patients with the diagnosis of BPH in our clinic were randomly divided into two groups (TURP and TUVAP).
💡
Conclusion & Impact:We believe that, plasmakinetic tissue treatment system, with TURP and TUVAP procedures, is an effective option in the treatment of BPH.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ürolojik cerrahi prosedürler · erkek · Prostatektomi

Abstract

Introduction: Recently, transurethral plasma vaporization (TUVAP) of BPH by using bipolar plasmakinetic technology has taken its role as a minimal invasive treatment option. In our current study, we compared two treatment modalities, TURP and TUVAP, by using bipolar plasmakinetic technology. Materials and Methods: 76 patients with the diagnosis of BPH in our clinic were randomly divided into two groups (TURP and TUVAP). When the preoperative parameters of the TURP and the TUVAP groups were compared, in both groups there was no statistically significant difference between the patients' values (p>0.05). After the operation perioperative and postoperative findings, preoperative and postoperative complications were recorded. Results: In TURP and TUVAP groups respectively, the operation time, the volume of fluid for irrigation found to be statistically significant. The time elapsed from the operative day until the withdrawal of urinary catheters was statistically significant when comparison was made in both groups (p<0.05). There was no statistically significant difference in the early and late findings and complications between the groups. Conclusion: TUVAP is as effective as TURP in decreasing the IPSS score and increasing Q maximum in patients with BPH. The shorter operative time and the shorter elapsed time with the urinary catheter in TUVAP decrease the complications. In both surgical procedures, the use of saline instead of giysine for irrigation prevents the TUR syndrome and decreases the cost. We believe that, plasmakinetic tissue treatment system, with TURP and TUVAP procedures, is an effective option in the treatment of BPH.

Özet

Son yılarda bipolar plazmakinetik teknolojisi kullanılarak BPtTnm transüretral plazma vaporizasyonu (TUVAP) minimal invazif tedavi seçenekleri arasında yerini almıştır. Bu çalışmamızda bipolar plazmakinetik teknolojisi kullanarak TURP ve TUVAP ameliyatlarını karşılaştırdık. 2002-2004 tarihleri arasında kliniğimizde BPH tanısı konan 76 hasta iki gruba randomize edildi (TURP ve TUVAP). TURP ve TUVAP gruplarının ameliyat öncesi ölçütleri karşılaştırıldığında gruplar arasında istatistiksel olarak anlamlı fark saptanmadı (p>0,05). Ameliyat sonrası ameliyat öncesi ve sonrası bulgular ve istenmeyen yan etkiler kaydedildi. TURP ve TUVAP gruplarında ameliyat süreleri, kullanılan irigasyon volümü istatistiksel olarak anlamlı bulunmuştur. Grupların ameliyat sonrası sondalı kalma süreleri TURP grubunda 2.8 iken TUVAP grubunda 2.3 gündü iki grup arasında istatistiksel olarak anlamlı fark vardı (p<0,05). Grupların 6. ay ameliyat sonrası bulguları ve istenmeyen yan etkileri arasında anlamlı fark gözlenmedi. TUVAP BPîTli hastalarda IPSS skorunu düşürmede ve Qmaksimumu artırmada TURP kadar etkilidir. TUVAP'ta ameliyat süresinin ve sondalı kalma süresinin kısa olması istenmeyen yan etki riskini azaltmaktadır. Her iki ameliyat tekniğinde irigasyon sıvısı olarak glisin yerine şalin kullanılması TUR sendromu gelişimini önler, maliyeti düşürür. Plasma kinetik doku tedavi sisteminin, TURP ve TUVAP ameliyatları ile BPH tedavisinde etkin bir seçenek olduğu kanaatindeyiz.

🔖

Cite This Article

ATALAY, A., KÜÇÜKPOLAT, S., TOKTAŞ, G., ÜNLÜER, E., KOÇAN, H., COŞKUN, E. (2007). Comparasion of transurethral resection (TURP) and transurethral plasmavapourasation (TUVAP) of prostate in benign prostatic hypertrophy patients by using plasmakinetic tissue treatment systems. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 33 - Sayı: 3, 308–316. https://ajindex.com/articles/328299

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mebust WK, Holtgrewe HL, Cockett ATK, et al: Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institations evaluting 3,885 patients. J Urol. 148: 243, 1989
  2. Narayan P, Twari A, Gorzatto M: Transurethral electro- vaporization of prostate: Physical principiles, result and complication. Urology. 47: 505, 1996
  3. Tewari AN, Arayan P: Electrovaporization of the prostate. Br J Urol. 78: 667-676, 1996
  4. Te AE, Kaplan SA, Dann JA: Transurethral, electro vaporization of the prostate (TVP), a novel method for treating men with benign prostatic hypeplasia: Comparison to laser TURP. J Urol. 153: 436 A, 1995
  5. Virdi J, Kapasi V, Chandrasekar P: A prospective randomized study between transurehral vaporisation using plasmakinetic energy and transurehral resection of the prostate. J Urol. 163: 1192, 2000
  6. Hamniadeh M, Madaan S, Sinngh M. Philp T: Transurethral electrovaporisation of the prostate; a possible alternative to standard TURP. Three year follow-up of a prospectively randomised trial. J Urol: 161 (Suppl): 391, 1999
  7. Botto H, Lebret T, Barre P, Orsoni JL, Herve TM, Lugagne PM: Electrovaporisation of the prostate with the Cyrus Device. J Endourol. 15: 313-6, 2001
  8. Shokier Al, Al-Sisi H, Parage YM, El-Maabound MA, Saeed M, Mutabagani H: Transurethral prostatectomy: A prospective randomized study of conventional resection and electrovaporization in bening prostatic hyperplasia. BrJ Urol; 80: 570-4, 1997
  9. Kaplan SA, Laor E, Fatal M, Te AE: Transurethral resection of the prostate versus transurethral electrovaporisation of the prostate: A blinded, prospective comparative study with 1- year follow-up. J Urol. 159: 454-8, 1998
  10. Talic RF, El Tirafi A, El Faqih SR, Hassan SH, Attassi RA, Abdel-Halim RE: Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology. 55: 886-90, 2000
  11. Helke C, Manseck A, Hakenberg OW, Wirth MP: Is transurethral vaporesection of the prostate better than standard transurethral resection? Eur Urol; 39: 551-7, 2001
  12. Dawkins GP, Miller RA: Sorbitol-mannitol solution forUrological electrosurgical resection: A safer fluid thanglycine 1.5%. Eur Urol. 36: 99-102, 1999
  13. Hammarsten J, Lidqvist K, Sunzel H: Urethral stricture following transurethral resection of the prostate. Therole of thecatheter. Br J Urol. 63: 397, 1989
  14. Hart AJL, Fowler JW: Incidence o